2'-Fucosyllactose (2'-FL)

2'-Fucosyllactose (2'-FL) is a human milk oligosaccharide that acts as a prebiotic by selectively feeding beneficial gut bacteria. It enhances immune function and gut health through direct binding to pathogenic bacteria and promotion of Bifidobacteria growth.

Origin & History

2'-Fucosyllactose (2'-FL) is a type of HMO found in human breast milk. It is produced synthetically for supplements using microbial fermentation techniques.

Historical & Cultural Context

2'-FL has been studied for its role in mimicking the benefits of breastfeeding, crucial for infant development.

Health Benefits

- Supports the growth of beneficial gut bacteria, enhancing gut health by increasing Bifidobacteria levels by up to 20%. This fosters a balanced microbiome, crucial for overall wellness. - Strengthens the immune system by modulating immune responses, reducing the risk of infections. This is achieved through the production of short-chain fatty acids. - Enhances cognitive development in infants by mimicking human milk oligosaccharides. This supports brain growth and function. - Reduces inflammation by promoting the production of anti-inflammatory cytokines. This can lead to a decrease in chronic disease risk. - Improves nutrient absorption by enhancing gut barrier function. This ensures that essential vitamins and minerals are efficiently utilized. - Lowers the risk of allergies by promoting immune tolerance. This is particularly beneficial in early childhood development. - Supports cardiovascular health by reducing cholesterol levels. This is achieved through the fermentation process in the colon.

How It Works

2'-FL selectively binds to α-1,2-fucosyltransferase receptors on beneficial bacteria like Bifidobacterium longum, promoting their proliferation. It acts as a decoy receptor for pathogenic bacteria, preventing their adhesion to intestinal epithelial cells. The compound stimulates short-chain fatty acid production, particularly butyrate, which strengthens intestinal barrier function.

Scientific Research

RCTs have shown 2'-FL's benefits in promoting gut health and immune function in infants. Studies confirm its safety and efficacy in infant nutrition.

Clinical Summary

Clinical trials with 60-200 participants show 2'-FL supplementation increases Bifidobacteria levels by 15-20% within 2-4 weeks. A randomized controlled trial of 175 adults demonstrated reduced infection rates and improved stool consistency scores. Most studies use doses of 2-20 grams daily, though long-term safety data beyond 6 months remains limited. Evidence is moderate but growing for gut health benefits.

Nutritional Profile

- A specific type of HMO, composed of fucose and lactose. - Non-digestible, serving as a prebiotic. - Mimics components found in human breast milk.

Preparation & Dosage

Commonly included in infant formulas; dosage varies. Consult a healthcare provider before use.

Synergy & Pairings

Probiotics, DHA, Lactoferrin

Safety & Interactions

2'-FL is generally recognized as safe (GRAS) by the FDA with minimal reported side effects. Some individuals may experience mild digestive discomfort, bloating, or gas during initial supplementation. No significant drug interactions are documented, though it may enhance the effectiveness of probiotics when taken concurrently. Pregnant and breastfeeding women should consult healthcare providers before supplementation despite its natural presence in breast milk.